Indications
Zalviso is indicated for the management of acute moderate to severe post-operative pain in adult patients.
Composition
- Active substance
- sufentanil
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Zalviso
- Active substance
- sufentanil
- ATC code
- N01AH03
- Group
- Nervous system
- Therapeutic area
- Pain, Postoperative
- Marketing authorisation holder
- FGK Representative Service GmbH
- Status
- Withdrawn
- EU authorisation
- 18 Sept 2015
- EMA product number